Interplay of the microbiome and antifungal therapy in recurrent vulvovaginal candidiasis (RVVC): A narrative review
Journal of Medical Microbiology · 2023
DOI: 10.1099/jmm.0.001705 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medical Microbiology, 2023. Verfasst von Moira Bradfield Strydom und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD, Australia. Hauptthemen laut MEDLINE: Candidiasis, Vulvovaginal, Microbiota. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Recurrent vulvovaginal candidiasis (RVVC) is a microbial, immune and sexual health disorder impacting up to 10 % of the adult female population. Fluconazole is a well-established antifungal drug commonly utilized for acute and long-term RVVC treatment. This insight review provides an overview of known vaginal and gastrointestinal microbiota characteristics in RVVC, presents the potential impacts of fluconazole therapy on multi-microbiome relationships and discusses implications for future research and clinical practice. Next-generation sequencing (NGS) and molecular methods to accurately define vaginal microbiota trends in RVVC are not comprehensively available, limiting understanding of microbiota roles in RVVC. Inconsistencies and variances in Lactobacillus profiles in RVVC women suggest poorly understood disease implications on the bacterial and fungal microbiomes. Investigations of environmental conditions like vaginal pH, drug therapy’s impact, especially fluconazole maintenance therapy, and the elucidation of multi-microbiome relationships in RVVC are required to further investigate disease pathogenesis and responsible antimicrobial prescribing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, QLD, Australia.
- Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD, Australia.
- School of Health Sciences, Faculty of Medicine and Health, UNSW Sydney, Sydney, NSW, Australia.
Zitieren
APA
Bradfield Strydom, M., Khan, S., Walpola, R. L., Ware, R. S., & Tiralongo, E. (2023). Interplay of the microbiome and antifungal therapy in recurrent vulvovaginal candidiasis (RVVC): A narrative review. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.001705
Vancouver
Bradfield Strydom M, Khan S, Walpola RL, Ware RS, Tiralongo E. Interplay of the microbiome and antifungal therapy in recurrent vulvovaginal candidiasis (RVVC): A narrative review. Journal of Medical Microbiology. 2023. doi:10.1099/jmm.0.001705
BibTeX
@article{BradfieldStrydom2023,
author = {Bradfield Strydom, Moira and Khan, Sohil and Walpola, Ramesh L and Ware, Robert S and Tiralongo, Evelin},
title = {Interplay of the microbiome and antifungal therapy in recurrent vulvovaginal candidiasis (RVVC): A narrative review},
journal = {Journal of Medical Microbiology},
year = {2023},
doi = {10.1099/jmm.0.001705}
}
EUVIMED